This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Triumeq
  • /
  • A Phase IIIb Study of the Safety, Efficacy, and To...
Clinical trial

A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral Regimen

Read time: 2 mins
Last updated:1st Apr 2014
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest